Healthcare entity
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Gaudium IVF and Women Health, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Gaudium IVF and Women Health, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Gaudium IVF appears in 1 tracked Healthcare story from February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gaudium IVF. Shared-story counts are live from our verified record — not editorial picks.
Gaudium IVF and Women Health's initial public offering has reached its final day of bidding, showing robust investor interest with a 3x subscription rate by the end of Day 2. The offering is currently trading at a 6.33% premium in the grey market, reflecting positive sentiment toward the specialized fertility services sector in India.
Gaudium IVF is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
